Mylan: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
Rescuing 1 sources and tagging 0 as dead.) #IABot (v2.0.8 |
Rescuing 5 sources and tagging 0 as dead.) #IABot (v2.0.8 |
||
Baris 57:
Mylan resmi melantai di pasar OTC pada bulan Februari 1973.<ref>{{Cite web|url=http://www.fundinguniverse.com/company-histories/mylan-laboratories-inc-history/|title=History of Mylan Laboratories Inc. – FundingUniverse|website=www.fundinguniverse.com|language=en|access-date=2018-06-11}}</ref> Sahamnya diperdagangkan di NASDAQ,<ref>{{Cite web|url=http://www.marketwatch.com/investing/stock/myl|title=Mylan N.V.|website=MarketWatch|access-date=2018-06-11}}</ref> dan sahamnya merupakan komponen dari [[Indeks Bioteknologi NASDAQ]]<ref>{{Cite web|url=http://www.nasdaq.com/symbol/ibb|title=iShares Nasdaq Biotechnology Index Fund (IBB)|website=NASDAQ.com|language=en-us|access-date=2018-06-11}}</ref> serta indeks [[S&P 500]].<ref>{{Cite web|url=http://marketrealist.com/2017/10/mylan-inc-sp-500s-top-gainer-october-4/|title=Market Realist|website=marketrealist.com|access-date=2018-06-11}}</ref>
Perusahaan ini mengembangkan dan memproduksi obat untuk berbagai macam disiplin medis, termasuk [[onkologi]], [[anafilaksis]], [[Penanganan HIV/AIDS|antiretroviral]], [[Sistem peredaran darah|kardiovaskular]], [[sistem pernapasan|pernapasan]], [[dermatologi]], [[imunologi]], [[anestesi]] dan [[manajemen sakit]], [[Infeksi|penyakit infeksi]], [[gastroenterologi]], diabetologi/[[endokrinologi]], dan perawatan kesehatan wanita.<ref>{{Cite web|url=http://www.mylan.com/en/products/therapeutic-innovation|title=Therapeutic Innovation|website=www.mylan.com|access-date=2018-08-08|archive-date=2018-08-08|archive-url=https://web.archive.org/web/20180808104714/http://www.mylan.com/en/products/therapeutic-innovation|dead-url=yes}}</ref>
Pada tahun 2016, harga yang ditetapkan Mylan terhadap produk EpiPen, sebuah [[autoinjektor epinefrin]], menjadi kontroversi dan banyak disebut sebagai "pencungkilan harga". Sebagai hasilnya, investigasi pun diadakan untuk mengetahui apakah Mylan telah salah mengklasifikasikan EpiPen di bawah [[Program Rabat Obat Medicaid]], sebuah bentuk umum dari [[penipuan farmasi]]. Pada bulan Oktober 2016, Mylan mengadakan perdamaian dengan Departemen Kehakiman Amerika Serikat, dengan setuju membayar $465 juta dan meneken [[perjanjian integritas perusahaan]] terkait program rabat. Pada sebuah laporan yang diterbitkan pada tanggal 12 Juni 2017, [[Institutional Shareholder Services]] mengkritisi Mylan atas "kompensasi berlebihan" terhadap direkturnya. Mantan CEO Mylan, Robert Coury menerima paket upah sebesar $98 juta pada tahun 2016, walaupun nilai saham Mylan mengalami penurunan dan adanya kontroversi mengenai EpiPen. Laporan inipun mendesak para pemegang saham Mylan untuk memecat semua direktur Mylan yang sedang menjabat.<ref name="CNN_CEO_revolt">{{cite news |url=http://money.cnn.com/2017/06/13/investing/epipen-mylan-exec-pay-shareholder-revolt/index.html?sr=twCNN061417epipen-mylan-exec-pay-shareholder-revolt0246AMStoryLink&linkId=38675750 |title=EpiPen maker faces revolt over exec's $98 million pay package |first=Matt |last=Egan |work=CNN Money}}</ref>
Baris 79:
*Mylan New Zealand Limited, asal Auckland, [[New Zealand]]
*Mylan Laboratories Limited - berkantor pusat di [[Hyderabad, India]] dan mengoperasikan sekitar selusin pabrik di India dan [[Tiongkok]]<ref>{{Cite web|url=http://www.mylan.in/-/media/mylanin/documents/english/india-mylan-fact-sheet-march-2016.pdf?la=en|title=Better health for a better world|date=March 2016|access-date=11 June 2018|archive-date=2018-06-12|archive-url=https://web.archive.org/web/20180612142449/http://www.mylan.in/-/media/mylanin/documents/english/india-mylan-fact-sheet-march-2016.pdf?la=en|dead-url=yes}}</ref>
*Mylan Seiyaku Ltd. asal Tokyo, [[Japan]]<ref>{{Cite web|url=http://www.jpma.or.jp/english/about_us/member_lib/m050007.html?height=170&width=420|title=Japan Pharmaceutical Manufacturers Association (JPMA)|website=www.jpma.or.jp|access-date=2018-06-11}}</ref>
*[[Alphapharm]] asal [[Australia]]<ref>{{Cite web|url=http://www.mylan.com.au/en-au/contact-mylan|title=Contact {{!}} Mylan|website=www.mylan.com.au|access-date=2018-06-11|archive-date=2018-06-12|archive-url=https://web.archive.org/web/20180612140422/http://www.mylan.com.au/en-au/contact-mylan|dead-url=yes}}</ref>
*Agila Specialties Pvt. Ltd. asal [[Bangalore]], [[Karnataka]], [[India]]<ref>{{Cite web|url=https://www.bloomberg.com/research/stocks/private/snapshot.asp?privcapId=116852053|title=Agila Specialties Private Limited: Private Company Information - Bloomberg|website=www.bloomberg.com|access-date=2018-06-11}}</ref>
*OncoTherapies Ltd. asal [[Bangalore]], [[Karnataka]], [[India]]<ref>{{Cite news|url=http://www.dnaindia.com/business/report-mylan-recalls-bangalore-unit-cancer-drug-2095955|title=Mylan recalls Bangalore unit cancer drug|date=2015-06-16|work=dna|access-date=2018-06-11|language=en-US}}</ref><ref name="Global">{{cite web|url=http://www.mylan.com/global_reach/APAC.aspx|title=About Us|work=mylan.com|access-date=2020-07-06|archive-date=2013-11-26|archive-url=https://web.archive.org/web/20131126234656/http://mylan.com/global_reach/APAC.aspx|dead-url=yes}}</ref>
Baris 91:
* Generics Pharma Hellas asal [[Yunani]]<ref>http://www.manta.com/coms2/dnbcompany_wsklv1</ref>
* Gerard Laboratories asal [[Irlandia]]<ref>{{Cite news|url=https://www.rte.ie/news/2012/0418/317502-major-jobs-announcement-set-for-later-today/|title=Mylan to create 500 jobs in €380m expansion|date=2012-04-18|work=RTE.ie|access-date=2018-06-11|language=en}}</ref>
* Docpharma - Distributor farmasi generik yang beroperasi di Belgia,<ref>{{Cite web|url=https://archives-energycommerce.house.gov/sites/republicans.energycommerce.house.gov/files/Hearings/Health/20120209/HHRG-112-IF14-TTF-HBresch-20120209.pdf|title=Committee on Energy and Commerce|access-date=11 June 2018|archive-date=2018-09-24|archive-url=https://web.archive.org/web/20180924130024/https://archives-energycommerce.house.gov/sites/republicans.energycommerce.house.gov/files/Hearings/Health/20120209/HHRG-112-IF14-TTF-HBresch-20120209.pdf|dead-url=yes}}</ref> Belanda, dan Luxembourg<ref name="Global" />
==Kantor pusat==
Didirikan pada tahun 1961, perusahaan ini awalnya berlokasi di sebuah [[gelanggang es]] terbengkalai di [[White Sulphur Springs, Virginia Barat|White Sulphur Springs]], [[Virginia Barat]].<ref name="PuskarObit">{{cite news|last1=Dearment|first1=Alaric|title=Milan Puskar, co-founder of Mylan, dies|url=http://www.drugstorenews.com/article/milan-puskar-co-founder-mylan-dies|work=Drug Store News|date=October 10, 2011|access-date=2020-07-06|archive-date=2017-05-03|archive-url=https://web.archive.org/web/20170503102747/http://www.drugstorenews.com/article/milan-puskar-co-founder-mylan-dies|dead-url=yes}}</ref><ref>{{Cite web|url=http://www.wvexecutive.com/a-tale-of-two-entrepreneurs/|title=A Tale of Two Entrepreneurs|website=www.wvexecutive.com|language=en-US|access-date=2018-07-01}}</ref> Perusahaan ini kemudian pindah ke Pennsauken, New Jersey pada tahun 1962,<ref>{{Cite book|url=https://books.google.com/?id=bDubfivyILEC&pg=PA7&lpg=PA7&dq=Pennsauken+mylan#v=onepage&q=Pennsauken%20mylan&f=false|title=Mylan: 50 Years of Unconventional Success : Making Quality Medicine Affordable and Accessible|last=Seaman|first=John T.|last2=Landry|first2=John T.|date=2012-04-10|publisher=UPNE|isbn=9781611682700|language=en}}</ref> ke Princeton, Virginia Barat pada tahun 1963, kemudian ke [[Morgantown, Virginia Barat|Morgantown]], Virginia Barat, pada tahun 1965, dan pada tahun 1976, Mylan memindahkan kantor pusatnya ke [[Canonsburg]], [[Pennsylvania]]. Pada tahun 2004, kantor pusat Mylan kembali dipindah ke dekat [[Southpointe]], sebuah kawasan bisnis di [[Cecil Township, Pennsylvania|Cecil Township]].<ref>{{cite web
|url=http://www.mylan.com/about_us/company_history.aspx
|title=Mylan 50 years young and still making history
| |||